Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA)

CUSIP: 67644C104

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-335,443
Put/Call ratio
35%
SEC-reported price per share
$0.98
Number of holders
19
Value change
-$391,768
Number of buys
4
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
39,127,596

Security key

67644C104

Report period

Q3 2024

Institutions

19

Top holders

10

Ownership snapshot

Top reported holders of OCEA - Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Chirinjeev Kathuria
Disclosed value leader
Polar Asset Management Pa...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $3,218,595 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Polar Asset Management Partners Inc. has the largest disclosed position value at $3.22M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Polar Asset Management Partners Inc.'s linked filing trail.
Disclosed position value Top 5
Polar Asset Management Partners Inc. $3.22M
VANGUARD GROUP INC $496K
BOOTHBAY FUND MANAGEMENT, LLC $255.7K
MILLENNIUM MANAGEMENT LLC $205.1K
GEODE CAPITAL MANAGEMENT, LLC $174.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Chirinjeev Kathuria
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
22,799,608 shares
— 02 Oct 2023
Aesther Healthcare Sponsor, LLC
3/4/5
10%+ Owner
—
denominator unverified
—
2,625,000 shares
— 03 Nov 2021
Polar Asset Management Partners Inc.
13F
Company
13F
—
denominator unverified
$3,218,595
2,688,193 shares
— 30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$495,966
406,529 shares
— 30 Jun 2024
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$255,716
209,603 shares
— 30 Jun 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$205,122
168,133 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
19
Shares
3,582,574
Rows available
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
31
Q3 2024 holders
19
Holder diff
-12
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .